Wilbe
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Apoha
3 Jun 2026
Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
Apoha has built a platform that measures how molecules, formulations and materials behave under real-world conditions, generating a new class of empirical data it calls Liquid State Intelligence. Its first product, VIBE, takes a microscopic sample, applies controlled stresses in liquid, and captures the resulting wave patterns as more than 1,000 behavioural descriptors - used by pharma, food and materials companies to predict product performance before costly late-stage failure.
Cyclana Bio
20 Oct 2025
Cyclana Bio raises £5m pre-seed led by NfX and Eka VC to advance drug discovery for endometriosis through tissue-level therapeutics
Cyclana Bio develops tissue level disease models to discover new treatments for endometriosis, using whole tissue analysis rather than traditional cell focused drug discovery methods.
Wilbe
- 2(12 months)
- wilbe.com/home
- Update Information
More venture news
- 9 Sept 2026
ViaNautisViaNautis secures investment from SCI Ventures to deliver non-viral genetic medicines to cells at spinal cord injury sites
EquityLife Sciences - 9 Sept 2026
CloudNCCloudNC lands £15m in funding led by Nimble Ventures to reduce bottlenecks in precision machining
EquityIndustrial - 9 Sept 2026
KVectorKVector raises £3.8m in funding from VCs to develop low-power radar antennas
EquityTelecoms
